Leveraging H2O2 Levels for Biomedical Applications
Carolina Digital Repository (University of North Carolina at Chapel Hill) · 03.04.2026
DOI: 10.17615/v63t-qv21 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carolina Digital Repository (University of North Carolina at Chapel Hill), erschienen am 03.04.2026. Verfasst von Edikan A. Ogunnaike und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Hydrogen peroxide (H2 O2 )-responsive materials have been employed as drug delivery or diagnostic systems to treat or detect diseases with abnormal oxidative stress. A number of H2 O2 -responsive systems have been developed, and they have achieved great progress in controlled drug delivery for disease treatment. However, pathological sites with elevated H2 O2 level, such as cancer and inflammation, have their own characteristics; therefore the material structures and the subsequent formulations should be reasonably designed to acquire maximized therapeutic effects. In this progress report, we overview the development of H2 O2 -responsive functional groups for constructing H2 O2 -responsive formulations, as well as the guidance for designing suitable formulations to treat each specific pathological condition. The challenges and perspectives in this field are also discussed.
Schlagwörter
Zitieren
APA
Ogunnaike, E. A., Wang, J., Zhang, Y., Ligler, F. S., & Gu, Z. N. (2026). Leveraging H2O2 Levels for Biomedical Applications. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/v63t-qv21
Vancouver
Ogunnaike EA, Wang J, Zhang Y, Ligler FS, Gu ZN. Leveraging H2O2 Levels for Biomedical Applications. Carolina Digital Repository (University of North Carolina at Chapel Hill). 2026. doi:10.17615/v63t-qv21
BibTeX
@article{Ogunnaike2026,
author = {Ogunnaike, Edikan A. and Wang, Jinqiang and Zhang, Yuqi and Ligler, Frances S. and Gu, Zhen Nan},
title = {Leveraging H2O2 Levels for Biomedical Applications},
journal = {Carolina Digital Repository (University of North Carolina at Chapel Hill)},
year = {2026},
doi = {10.17615/v63t-qv21}
}
EUVIMED